Skip to main content

GlaxoSmithKline Pharmaceuticals

GlaxoSmithKline Pharmaceuticals Ltd, operating as GSK India, is an Indian pharmaceutical enterprise manufacturing and marketing prescription drugs and vaccines across India. Operating as a subsidiary of the global GSK group, the company formulates, packages, and distributes prescription pharmaceuticals targeting dermatology, anti-infectives, respiratory diseases, oncology, and pediatric vaccines like Infanrix and Synflorix. Principal revenues derive from wholesale pharmaceutical product sales directly to medical distributors, hospital networks, and retail pharmacy chains across India. Core end markets encompass prescription patients, pediatric clinics, clinical hospital networks, and retail pharmacies throughout India. GSK India holds a market-leading position in the Indian pharmaceutical industry for pediatric vaccines and prescription anti-infectives. The company is headquartered in Mumbai, India, and its equity shares trade on the BSE and National Stock Exchange of India.

5 of the funds FundTelligence covers report a position in GlaxoSmithKline Pharmaceuticals.

Legal name
GlaxoSmithKline Pharmaceuticals Ltd
Sector
Health Care
Country
India
Funds holding it
5

Funds holding GlaxoSmithKline Pharmaceuticals

Loading...